NPI registry status
Active
2026 NPPES data Podiatrist NPI 1205873155 DPM
Verify on CMS → Joseph Dimenna III, DPM
Podiatrist in Cherry Hill, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 10,602 in Podiatrist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
814
Medicare Part D claims · 309 beneficiaries · Podiatrist avg: 320
Generic prescribing
95%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.5 · Exceptional
Industry payments
$1.2K
28 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Joseph Dimenna III, DPM reported a CMS MIPS final score of 100/100 - above the 83.5 national average - and filed 814 Medicare Part D claims in 2024.
- 100/100
- MIPS score · +17 vs avg
- 814
- Part D claims, 2024
- 95%
- generic prescribing
- $1.2K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Joseph Dimenna III, DPM
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1205873155), first enumerated 06/01/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 814 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 100/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$1.2K in reported industry payments (28 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1205873155 · Podiatrist
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-ELITE · RX-LIGHT · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1205873155
- ENUM-LEGACY 2006
- TAX-MID 11K Podiatrist
- MIPS-ELITE 100/100
- RX-LIGHT 814
- BOOK-LIGHT 526 in New Jersey
- PHOTO-FINISH David Abdoo · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Dimenna III · th…
Dimenna III · this provider
100 MIPS pts
- Mariaines Apolo …
Mariaines Apolo
100 MIPS pts
- David Abdoo · near
David Abdoo
100 MIPS pts
- Johnnie Alston ·…
Johnnie Alston
100 MIPS pts
- Mariam Amiri · n…
Mariam Amiri
100 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Joseph Dimenna III, DPM's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
100 ≥ 92nd percentile 92% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Joseph Dimenna III, DPM sits
This provider among podiatrist peers
Across the 2,362 podiatrist providers who report both Medicare Part D prescribing and a MIPS quality score, Joseph Dimenna III, DPM writes more Part D claims than 93% of them and scores higher on MIPS quality than 94% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one podiatrist peer from a representative sample of 60; the gold marker is Joseph Dimenna III, DPM. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Joseph Dimenna III, DPM?
High performer (top quartile)Primary specialty
Podiatrist
Medicare Part D claims
814 154% vs specialty avg
MIPS final score
100/100 16.5 pts vs avg
Specialty distribution in New Jersey
How Podiatrist compares to other specialties among New Jersey providers
Medicare quality performance, MIPS
Joseph Dimenna III, DPM's 2023 MIPS final score plotted against the Podiatrist national average
- MIPS Final Score
- 100/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1205873155 |
|---|---|
| Specialty | Podiatrist |
| Credentials | DPM |
| Gender | Male |
| NPI Issued | 06/01/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
100
Final Score
Measured-score avg: 83.5
100
Quality
Reporting: Group practice
Hospital and facility affiliations
Facilities where Joseph Dimenna III, DPM bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Family Foot And Ankle Center OF South Jersey
Voorhees, NJ
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Joseph Dimenna III, DPM. Source: openpaymentsdata.cms.gov.
Total received
$1.2K
Largest payer
Stryker Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
Joseph Dimenna III, DPM - brand share 5.0%
Podiatrist average
5% brand-name claims vs 95% generic, on 814 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
814
Total Claims
$51K
Total Drug Cost
309
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 984.167
- Total Day Supply
- 23,053
- Brand vs Generic
- 5% brand / 95% generic
- Brand Drug Cost
- $38K
- Generic Drug Cost
- $13K
- Opioid Claims
- 32 (3.9% rate)
- Antibiotic Claims
- 155
Patient Demographics
- Average Patient Age
- 73.6 years
- Avg HCC Risk Score
- 1.37
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 37, 65-74: 122, 75-84: 113, 85+: 37
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Joseph Dimenna III, DPM prescribes most
Top Medicare Part D drugs by claim count, 2024
- Mupirocin
Mupirocin
125 claims
- Ketoconazole
Ketoconazole
119 claims
- Ciclopirox
Ciclopirox
108 claims
- Doxycycline Hyclate 45
Doxycycline Hyclate
45 claims
- Cephalexin 42
Cephalexin
42 claims
- Gabapentin 36
Gabapentin
36 claims
- Methylprednisolone 28
Methylprednisolone
28 claims
- Sulfamethoxazole-T… 27
Sulfamethoxazole-Trimethoprim
27 claims
| Drug | Claims |
|---|---|
| Mupirocin | 125 |
| Ketoconazole | 119 |
| Ciclopirox | 108 |
| Doxycycline Hyclate | 45 |
| Cephalexin | 42 |
| Gabapentin | 36 |
| Methylprednisolone | 28 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 27 |
| Jublia Efinaconazole | 26 |
| Allopurinol | 25 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Podiatrist Overview
How Joseph Dimenna III, DPM fits within the Podiatrist landscape nationally.
10,602
Podiatrist Providers in US
54
States with Podiatrist
320
Avg Claims per Provider
Joseph Dimenna III, DPM's 814 claims are above the specialty average of 320.
Nationwide Podiatrist peers with similar MIPS or enrollment year
Two federal-record peer sets for Dimenna III, both outside New Jersey so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (100 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Podiatrist Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Dimenna III.
One of 526 Podiatrist providers enrolled in New Jersey, 5 are shown here.
Dr. Anthony Acello
DPM
Edison, NJ
Dr. Richard Adler
D.P.M.
Cherry Hill, NJ
Scott Agins
DPMD
Irvington, NJ
Dr. Maarij Ahmed
DPM
Marlton, NJ
Dr. Nafis Ahmed
DPM
Denville, NJ
Compare Podiatrist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Joseph Dimenna III, DPM's specialty? ▼
Joseph Dimenna III, DPM specializes in Podiatrist and practices in Cherry Hill, New Jersey. Credentials: DPM.
How much does Joseph Dimenna III, DPM prescribe under Medicare Part D? ▼
In 2024, Joseph Dimenna III, DPM wrote 814 Medicare Part D claims totaling $51K in drug costs for 309 beneficiaries.
What is Joseph Dimenna III, DPM's Medicare quality score? ▼
Joseph Dimenna III, DPM has a CMS MIPS Final Score of 100/100 (Quality: 100). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Joseph Dimenna III, DPM located? ▼
Joseph Dimenna III, DPM is located at 496 KINGS HWY N STE 210, Cherry Hill, NJ, 08034. Phone: (908) 968-9322.
What is Joseph Dimenna III, DPM's NPI number? ▼
Joseph Dimenna III, DPM's National Provider Identifier (NPI) is 1205873155, issued on 06/01/2006.
Does Joseph Dimenna III, DPM prescribe more brand-name or generic drugs? ▼
Joseph Dimenna III, DPM's prescribing is 5% brand-name and 95% generic drugs by claim count, with $38K in brand drug costs.
Does Joseph Dimenna III, DPM prescribe opioids? ▼
Yes, Joseph Dimenna III, DPM had 32 opioid claims in 2024 with an opioid prescribing rate of 3.9%.
How many Podiatrist providers are there in the US? ▼
There are 10,602 Podiatrist providers across 54 states in the US. The average Podiatrist provider writes 320 Medicare Part D claims per year.
What drugs does Joseph Dimenna III, DPM prescribe most often? ▼
Based on 2024 Medicare Part D data, Joseph Dimenna III, DPM's most frequently prescribed drugs include Mupirocin, Ketoconazole, Ciclopirox. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Joseph Dimenna III, DPM accept Medicare? ▼
Joseph Dimenna III, DPM appears in CMS Medicare data with 814 Part D claims and 309 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Joseph Dimenna III, DPM's credentials? ▼
Joseph Dimenna III, DPM's NPI is 1205873155 with credentials DPM. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.